Indications:

effective in controlling neuropathic type of pain (e.g painful diabetic Neuropathy , low back pain with radiculopathy, trigeminal neuralgia & post-herpetic Neuralgia ). an add-on antiepileptic treatment in patial seizures And is also a mood stabilizer in bipolar disorder.

Contraindications:

Patients who are hypersensitive to gabapentin

Adverse reactions:

Body as a Whole: Asthenia, malaise, facial edema. Cardiovascular System: Hypertension. Digestive System: Flatulence, anorexia, gingivitis. Hemic, Lymphatic Systems: Purpura most often described as bruises resulting from physical trauma. Musculoskeletal System: Arthralgia. Nervous System: Vertigo, hyperkinesia; increased, decreased or absent reflexes; paresthesia, anxiety, hostility. Respiratory System: Pneumonia. Urogenital System: Urinary tract infection. Special Senses: Abnormal vision most often described as a visual disturbance. Monotherapy: No new and unexpected adverse events were reported during the clinical trials for monotherapy. Dizziness, ataxia, somnolence, paresthesia and nystagmus showed a dose relationship when comparing 300 with 3600 mg/day. Geriatric Use: Fifty-nine individuals greater than or equal to 65 years received gabapentin in premarketing clinical trials. Side effects reported among these patients did not differ in kind from those reported in younger individuals. For patients with compromised renal function, the dosage should be adjusted. (See Dosage & Administration.) Pediatric Use: The most commonly observed adverse events reported with the use of gabapentin in combination with other antiepileptic drugs in children 3-12 years, not seen in equal frequency among placebo-treated patients, were viral infection, fever, nausea and/or vomiting, and somnolence.

Interactions:

A slight decrease in renal excretion of gabapentin that is observed when it is co-administered with cimetidine is not expected to be of clinical importance.

Warnings:

Pregnancy: Category C,

Form:

Oral solution